News Center


新闻中心

05-10

Approved for listing | Xinhuan Biotech's new coronavirus lgM antibody detection kit obtains registration certificate

2020-05-10

Recently, Beijing Xinxing Sihuan Biotechnology Co., Ltd. (hereinafter referred to as: Xinhuan Biotechnology) received the registration certificate for the new coronavirus (2019-nCoV) IgM antibody detection kit issued by the National Medical Products Administration.

01-01

Relocation

2018-01-01

In August 2018, the company successfully moved to the biomedical industry base in Daxing District, Zhongguancun Science Park, with a total factory area of 4,000 square meters. Through the introduction and cultivation of talents, a high-quality professional talent team including management, research and development, quality control, production and marketing has been established, and the administrative personnel department, financial department, marketing department, R&D department, quality department, and production department have been set up and improved. , Engineering Equipment Department, Warehousing and Logistics Department and Supply Department, etc., formed a strict and comprehensive quality control system and a complete organization.
Relocation

01-01

Recognized as a high-tech enterprise

2015-01-01

So far, the company has obtained a total of 45 products with national approval number, and many products are under research. With the continuous investment in research and development and the continuous improvement of the management team, the company has developed rapidly, and the sales performance has doubled year by year.
Recognized as a high-tech enterprise

01-01

Expansion

2014-01-01

The plant was upgraded and renovated, adding 500 square meters for storage and instrument equipment development, and adding an office and service center of 1,100 square meters in Sanli Industrial Park, which further met the requirements of relevant national laws and regulations and the further development of the enterprise. It provides a strong guarantee for the realization of high-quality products.
Expansion

01-01

Realize integrated management

2011-01-01

At the beginning of 2011, the company increased investment in research and development, established a protein expression platform, established strains through cooperation and commercial purchase, and realized the self-production of some biological raw materials, thus enabling the company to form self-production of biological raw materials, research and development and production of finished products, and sales Integrated business model.
Realize integrated management
< 123 > proceed page